Brown and another physician specializing in obesity management, Meena Malhotra, MD, unpack what patients should know before going off a GLP-1
Privacy and Security Requirements HIPAA Compliance (Federal): All telehealth providers must: Protect patient health information Use secure, encrypted platforms Have privacy policies Obtain patient consent Report breaches State Privacy Laws: Some states have additional requirements: California (CCPA) Virginia (VCDPA) Other state-specific privacy laws Legitimate providers: Use HIPAA-compliant video platforms Secure messaging systems Encrypted data storage Clear privacy policies BAA (Business Associate Agreements) with partners State-Specific Examples Texas: Allows asynchronous consultations Provider must be licensed in Texas Relatively permissive telehealth laws Large telehealth market New York: May require more documentation Stricter telemedicine regulations Video consultation often preferred over asynchronous TrimRx serves New York with compliant processes California: Robust telehealth infrastructure Provider licensing required Generally permissive for GLP-1s Large market for telehealth services Florida: Allows telehealth for weight loss Provider must be Florida-licensed Relatively straightforward regulations Arkansas: More restrictive telehealth laws historically May have additional requirements Fewer providers serve Arkansas How to Check Your State: Verify Telehealth Access: Check provider website for state coverage list State boards of medicine often have telehealth info Ask provider directly about state regulations Confirm during consultation process Most states allow GLP-1 prescribing via telehealth, but specific requirements vary
It works well as a light breakfast, a gentle lunch, or a meal when you want something you can eat slowly
According to the results of the RCT for patients with monogenic obesity ( LEPR or POMC deficiency) and acquired hypothalamic obesity, setmelanotide can reduce body weight and inhibit appetite to a certain extent, and common adverse reactions include injection site reactions, skin hyperpigmentation, nausea, diarrhea, and abdominal pain, with occasional occurrences of sexual adverse reactions, depression, and suicidal ideation [51,52]
However, if the liver is damaged IGF-1 results will not be reliable
Unfortunately, it is frequently inappropriately prescribed
